Tag: Selenium

Posted on

Selenium Supplementation Strengthens Immune Response to Covid-19

The available vaccines do not seem up to the task of preventing infection by the fourth wave of the Covid-19 virus. Accordingly, people in high-risk groups may want to start on a course of supplementation to address possible deficiencies of selenium, zinc, and vitamin D to strengthen their immune response [Alexander 2020].

Covid-19 vaccine
Resistance to Covid-19 and other viral infections, strengthening of immune system function, and reducing chronic inflammation all depend on adequate intakes of zinc, selenium, and vitamin D [Alexander 2020].
In this article, we will address the importance of adequate selenium intakes. Readers are encouraged to google zinc and Covid-19 and vitamin D and Covid-19 on their own.

Early initiation of adequate selenium, zinc, and vitamin D supplementation in high-risk individuals and in high-risk areas and, certainly, as soon as possible after the time of suspected infection with the Covid-19 virus can help the immune system [Alexander 2020]. read more

Posted on

Selenium Status and Inflammation and Heart Disease

Low plasma selenium status is significantly associated with heart disease risk and with elevated blood bio-markers of chronic inflammation.  A 2021 cross-sectional study of elderly individuals in central Italy has revealed that individuals with a plasma selenium status lower than 60 mcg/L are especially at risk of heart disease [Giacconi 2021].

Ancona, Italy
Researchers in Ancona, Italy, have done a cross-sectional study that shows that low plasma selenium status is associated with increased risk of heart disease and with elevated levels of blood bio-markers for chronic inflammation.

Moreover, in the peripheral blood mononuclear cells of elderly individuals diagnosed with heart disease, the researchers found that low plasma selenium status was significantly associated with enhanced gene expression of inflammatory cytokines and chemokines and with a downregulation of sirtuins SIRT-1, SIRT-5, SIRT-6, and SIRT-7 [Giacconi 2021].

Note: The peripheral blood mononuclear cells are lymphocytes (e.g., T cells, B cells, NK cells) and monocytes as distinguished from such blood cells as erythrocytes, granulocytes, and platelets. read more

Posted on

Serum Selenium Status and Mortality Risk in Individuals with Hypertension

Serum selenium concentrations show a U-shaped association with all-cause mortality and with cardiovascular mortality in individuals with hypertension [Tan 2021].

Blood pressure measuredThis conclusion is based on an analysis of data from 929 individuals diagnosed with hypertension [Tan 2021].

  • The average age of the individuals was 63 years plus/minus 13 years.
  • Slightly more than half of the individuals were male: 53%.
  • The researchers followed the individuals for a mean period of slightly more than ten years: 121 months plus/minus 41 months.
  • During the follow-up period, 307 individuals died, including 56 individuals who died from cardiovascular disease.
Quartiles of Serum Selenium Status

For purposes of analysis, the researchers categorized the individuals with hypertension into quartiles of serum selenium concentration [Tan 2021]:

Q1: equal to or less than 124 mcg/L

Q2: 125-135 mcg/L

Q3: 136-147 mcg/L

Q4: greater than 148 mcg/L

Optimal Serum Selenium Levels in Individuals with Hypertension

The researchers compared the data from the serum selenium quartiles and found that the risk of death from all causes and death from heart disease were lowest in the third quartile (serum selenium concentrations between 136 and 147 mcg/L) [Tan 2021]. read more

Posted on

Plasma Selenoprotein P Levels and the Risk of Cardiovascular Disease

Research conclusion: “The 20% with lowest SELENOP concentrations in a N orth European population without history of cardiovascular disease have markedly increased risk of cardiovascular morbidity and mortality” [Schomburg 2019].

Heart attack
Selenoprotein-P deficiency predicts cardiovascular disease and death. Low selenium intakes result in sub-optimal bio-synthesis of selenoprotein P in the liver. Now, research shows that low selenoprotein P concentrations are associated with increased risk of cardiovascular disease and mortality.

This is the conclusion from the Malmö Preventive Project, a population-based prospective cohort study in southern Sweden, that examined the relationship between plasma selenoprotein P status and 1) risk of all-cause mortality, 2) risk of cardiovascular mortality, and 3) risk of a first cardiovascular event in 4366 study participants.

Note that this was a study done with study participants who had no history of cardiovascular disease. It was truly a study of the relationship between selenium status and the risk of heart disease. read more